Cargando…
DSTYK Promotes Metastasis and Chemoresistance via EMT in Colorectal Cancer
OBJECTIVE: Tumor metastasis and resistance to chemotherapy are two critical factors that contribute to the high death rate of colorectal cancer (CRC) patients. Metastasis is facilitated by the epithelial-mesenchymal transition (EMT) of tumor cells, which has emerged not only as a fundamental process...
Autores principales: | Zhang, Jinyu, Miller, Zachary, Musich, Phillip R., Thomas, Ashlin E., Yao, Zhi Q., Xie, Qian, Howe, Philip H., Jiang, Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7493073/ https://www.ncbi.nlm.nih.gov/pubmed/32982725 http://dx.doi.org/10.3389/fphar.2020.01250 |
Ejemplares similares
-
DSTYK Enhances Chemoresistance in Triple-Negative Breast Cancer Cells
por: Ogbu, Stella C., et al.
Publicado: (2021) -
Loss of DSTYK activates Wnt/β-catenin signaling and glycolysis in lung adenocarcinoma
por: Zhong, Chenxi, et al.
Publicado: (2021) -
EMT is not required for lung metastasis but contributes to chemoresistance
por: Fischer, Kari R., et al.
Publicado: (2015) -
DSTYK inhibition increases the sensitivity of lung cancer cells to T cell–mediated cytotoxicity
por: Valencia, Karmele, et al.
Publicado: (2022) -
EMT Program is Dispensable for Metastasis but Induces Chemoresistance in Pancreatic Cancer
por: Zheng, Xiaofeng, et al.
Publicado: (2015)